Literature DB >> 25968832

Cigarette Smoke Modulates NOD1 Signal Pathway and Human β Defensins Expression in Human Oral Mucosa.

Ya-Jie Qian1, Xiang Wang, Ya-Fan Gao, Ning Duan, Xiao-Feng Huang, Fang-Fang Sun, Xiao-Dong Han, Wen-Mei Wang.   

Abstract

BACKGROUND/AIMS: Nucleotide binding oligomerization domain 1 (NOD1) signal pathway and human β defensins (hBDs) play crucial roles in innate immune. Cigarette smoke has been confirmed to dampen innate immune in some human tissues, such as oral mucosa. The aim of this study was to evaluate potential effects of smoking on NOD1 signaling and hBDs expression in oral mucosa.
METHODS: Tissue specimens of normal oral mucosa were collected from donors undergoing routine surgical treatment. All 20 participants were classified equally as two groups: non-smokers and smokers. By using Western blotting and immunohistochemistry, we investigated differential expression of crucial molecules in NOD1 signal pathway, hBD-1, -2, and -3 in oral mucosa tissues between non-smokers and smokers. Immortalized human oral mucosal epithelial (Leuk-1) cells were treated with various concentrations of cigarette smoke extract (CSE) for 24h. Western blotting and immunofluorescence assays were performed to study CSE-induced alteration of protein expression. Leuk-1 cells were treated with 4% CSE, iE-DAP (NOD1 agonist), CSE + iE-DAP, BAY 11-7082 (NF-κB inhibitor), 4% CSE + BAY 11-7082, respectively. Real-time PCR and ELISA were performed to detect the mRNA levels and secretion of hBD-1, -2, and -3, respectively.
RESULTS: The levels of NOD1, NF-κB, hBD-1 and hBD-3 significantly reduced in oral mucosa tissues of smokers compared with non-smokers. The levels of RIP2 (receptor-interacting protein 2), phospho-NF-κB (P-NF-κB) and hBD-2 remarkably enhanced in oral mucosal tissues of smokers. CSE treatment suppressed NOD1 and NF-κB expression and activated RIP2 and P-NF-κB expression in Leuk-1 cells. The mRNA and secretory levels of hBD-1 and -3 were down-regulated by CSE, while the mRNA and secretory level of hBD-2 were up-regulated by CSE. The iE-DAP or BAY 11-7082 treatment reversed the regulatory effects of CSE on levels of hBDs.
CONCLUSION: The present study indicated that cigarette smoke could potentially modulate the expression of crucial molecules of NOD1 signal pathway and hBDs in human oral mucosal epithelium. NOD1 signal pathway could play an important role in the regulatory effects of CSE on hBDs levels in oral mucosal epithelial cells.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25968832     DOI: 10.1159/000430112

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  8 in total

1.  Membrane microdomains regulate NLRP10- and NLRP12-dependent signalling in A549 cells challenged with cigarette smoke extract.

Authors:  Dhirendra P Singh; Gagandeep Kaur; Prathyusha Bagam; Rakeysha Pinkston; Sanjay Batra
Journal:  Arch Toxicol       Date:  2018-04-06       Impact factor: 5.153

2.  NOD1 agonist iE-DAP reverses effects of cigarette smoke extract on NOD1 signal pathway in human oral mucosal epithelial cells.

Authors:  Yafan Gao; Wenhui Jiang; Yajie Qian; Qian Zhou; Hongliu Jiang; Xiang Wang; Wenmei Wang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 3.  NOD1-Targeted Immunonutrition Approaches: On the Way from Disease to Health.

Authors:  Victoria Fernández-García; Silvia González-Ramos; Paloma Martín-Sanz; José M Laparra; Lisardo Boscá
Journal:  Biomedicines       Date:  2021-05-06

4.  Airway surface liquid from smokers promotes bacterial growth and biofilm formation via iron-lactoferrin imbalance.

Authors:  Luis G Vargas Buonfiglio; Jennifer A Borcherding; Mark Frommelt; Gavin J Parker; Bryce Duchman; Oriana G Vanegas Calderón; Ruth Fernandez-Ruiz; Julio E Noriega; Elizabeth A Stone; Alicia K Gerke; Joseph Zabner; Alejandro P Comellas
Journal:  Respir Res       Date:  2018-03-10

5.  IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway.

Authors:  Leong-Perng Chan; Ling-Feng Wang; Feng-Yu Chiang; Ka-Wo Lee; Po-Lin Kuo; Chia-Hua Liang
Journal:  Oncotarget       Date:  2016-09-20

6.  Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis.

Authors:  Bo-Young Hong; Takanori Sobue; Linda Choquette; Amanda K Dupuy; Angela Thompson; Joseph A Burleson; Andrew L Salner; Peter K Schauer; Pujan Joshi; Evan Fox; Dong-Guk Shin; George M Weinstock; Linda D Strausbaugh; Anna Dongari-Bagtzoglou; Douglas E Peterson; Patricia I Diaz
Journal:  Microbiome       Date:  2019-04-25       Impact factor: 14.650

7.  Integrated Analysis of Clinical and Microbiome Risk Factors Associated with the Development of Oral Candidiasis during Cancer Chemotherapy.

Authors:  Patricia I Diaz; Bo-Young Hong; Amanda K Dupuy; Linda Choquette; Angela Thompson; Andrew L Salner; Peter K Schauer; Upendra Hegde; Joseph A Burleson; Linda D Strausbaugh; Douglas E Peterson; Anna Dongari-Bagtzoglou
Journal:  J Fungi (Basel)       Date:  2019-06-13

8.  Smoking increases oral mucosa susceptibility to Candida albicans infection via the Nrf2 pathway: In vitro and animal studies.

Authors:  Pei Ye; Wei Chen; Fan Huang; Qin Liu; Ya-Nan Zhu; Xiang Wang; Xiao-Dong Han; Wen-Mei Wang
Journal:  J Cell Mol Med       Date:  2021-06-21       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.